analysis of limiting dilution culture showed that about one per 140 IgG cells in the colonic mucosa synthesised anticolon antibody. Two monoclonal IgG antibodies were obtained from EBV transformed anticolon antibody secreting cells by limiting dilution method. One reacted with goblet cells in the intestine, and the other reacted mainly with colonic epithelial cells. These results suggest that heterogeneous anticolon antibodies are present in patients with ulcerative colitis and that colonic mucosa may be the main source of anticolon antibody. Local autoimmune reaction might have an important role in causing the inflammation of colonic mucosa in this disease.
Several lines of evidence suggest that autoimmune mechanisms may be concerned in the pathogenesis of ulcerative colitis.lA Autoantibodies that react with colonic epithelial cells are frequently found in the sera of patients with this disease.5 Our previous study using flow cytometry showed that the frequency of anticolon antibodies in the sera from patients with ulcerative colitis was 78%. 4 The properties of these antibodies have not been well explained. There are several reports that antibody dependent cell mediated cytotoxicity causes the lysis of colonic epithelial cells.9 A sensitive and simple assay for detecting anticolon antibodies has been developed using isolated colon epithelial cells. This has allowed screening for anticolon antibodies in the serum or culture supernatant. We examined whether peripheral blood or colon lymphocytes secreting anticolon antibodies could be detected in vitro in patients with ulcerative colitis, using Epstein-Barr virus (EBV) as a polyclonal B lymphocyte activator. In Y Iwao, N Watanabe, M Watanabe, Y Hamada, addition, monoclonal cell lines which could produce anticolon antibodies were established by limiting dilution and the characteristics of colon specific antigens were investigated by these ,antibodies.
Methods

SERA
Ulcerative colitis was diagnosed on the basis of typical clinical, radiographic, and pathological features. Sera were obtained from 41 patients with ulcerative colitis and 27 healthy hospital workers. The sex and age distribution of the healthy control group was comparable to that of the patients. The sera from 11 colitis and a healthy control subject was serially diluted and testedfor the binding to rat colon epithelial cells in an enzyme linked immunosorbent assay. In any dilution the serum from a patient with ulcerative colitis showed higher optical density than the serum from a healthy control subject.
reactivity of these monoclonal antibodies with indirect immunofluorescence.
Results
SERUM ANTICOLON ANTIBODY
To find out the proper dilution of the serum in the ELISA, the serum with high activity for anticolon antibody ascertained by fluorescence activator cell sorter analysis was tested in serial dilution. A representative experiment is shown in Figure 1 . In comparison with normal serum the optical density of the patient's serum was high in any dilution tested (Fig 1) . The differences in optical densities were remarkable in 1:25 or 1:50 dilution of the serum. In the following experiments 1:50 dilution was used. To examine the specificity of this assay absorption studies were undertaken on two sera with high activity for anticolon antibody. The sera were incubated with I x 101 rat or human colon epithelial cells for 3 hours at room temperature. The optical densities of these treated sera were reduced in comparison with those of the untreated sera and were similar to those of healthy control sera. Similarly, absorption with homogenised human colon mucosa abolished the reactivity of the sera to rat colon epithelial cells. It is possible that the non-specific binding of the serum IgG through Fc receptor on rat colon epithelial cells is also measured in this assay. To determine if the non-specific binding of the serum IgG influenced the ELISA, the following experiments were performed in eight positive sera. A large amount of purified rat IgG (CappelOrganon Teknika Corp, PA) (100 times higher than the normal concentration of IgG in the serum) was added to the serum to block the nonspecific binding of IgG in the tested serum. Then the optical densities of the treated sera were compared with those of the untreated sera. There was no significant difference between the optical densities of the sera added with a large amount of IgG (mean (2SD), 0-861 (0 202)) and those of the untreated sera (0-847 (0-249)). This meant that this assay did not pick up the nonspecific binding of IgG to the colonic epithelial cells. The absorption studies using human erythrocytes were performed, since the cross reactivity of rat colon antigens and human blood group A antigens has been reported by Hammarstrom et al." Packed and washed human A type erythrocytes were mixed with equal volumes of undiluted serum and the mixtures were incubated for 30 minutes at room temperature. The optical densities of the absorbed sera were compared with those of the unabsorbed sera. There was no significant difference in anticolon antibody activity between the unabsorbed sera (mean (2SD), 1-188 (0 329)) and the absorbed sera (0-928 (0 380)).
The correlation between the optical density in ELISA and per cent offluorescence positive cells in fluorescence activated cell sorter analysis were tested in patients' sera. There was a significant correlation (r=0-578, p<0 05). The frequency of anticolon antibodies is shown in Figure 2 . In the patients with ulcerative colitis there was a significant increase in the optical densities (mean (2SD) 0 852 (0-279)) compared with healthy control subjects (0 470 (0 142)). When the optical densities greater than two standard deviations above the mean ofthe healthy controls were scored as positive for anticolon antibody activity, the frequency of anticolon antibody was 71% in patients with ulcerative colitis. The sera from patients with Crohn's disease did not show high optical densities, but two sera were positive for anticolon antibody activity. The optical densities of the sera from nine patients with colon cancer and from five patients with colon diverticulosis were 0-383 (0 116) and 0-319 (0-08). These were not significantly higher than the optical densities of healthy control sera. and fluorescence activated cell sorter analysis, were isolated as shown in Table III In vitro anticolon antibody production by mucosal orperipheral blood lymphocytesfrompatients with ulcerative colitis 
Correction
In vitro anticolon antibody production by mucosal or peripheral blood lymphocytes from patients with ulcerative colitis by T Hibi et al, December 1990; 31: 1371-6. In this paper in Figure 3 (colour plate) parts a and b were inverted and parts c and d were inverted; thus in the legend a describes plate b, b describes a, c describes d and d describes c.
